Literature DB >> 20354664

Treatment results of radiation therapy for muscle-invasive bladder cancer.

Tanja Langsenlehner1, Carmen Döller, Franz Quehenberger, Heidi Stranzl-Lawatsch, Uwe Langsenlehner, Karl Pummer, Karin S Kapp.   

Abstract

PURPOSE: To assess local control and survival rates in patients with muscle-invasive bladder cancer treated with external-beam radiotherapy and to investigate prognostic factors. PATIENTS AND METHODS: Between 1997 and 2007, 75 patients (male, n = 58; female, n = 17, median age, 74.2 years) with localized transitional cell carcinoma of the bladder (T2, n = 34; T3, n = 32; T4, n = 9) not suitable for radical surgery due to advanced age, comorbidity or inoperability underwent external-beam radiotherapy without simultaneous chemotherapy at the University Clinic of Therapeutic Radiology and Oncology, Medical University of Graz, Austria. A conformal four-field technique was used in all patients to treat the tumor and regional lymph nodes with single daily fractions of 1.8-2 Gy to a total dose of 50-50.4 Gy, followed by a cone-down to encompass the empty bladder which was boosted to 70-70.4 Gy. All patients had undergone transurethral tumor resection prior to radiotherapy which was macroscopically incomplete in 62 patients.
RESULTS: Complete response was achieved in 65% of patients. Actuarial 3-year local control and metastases-free survival rates were 52.5% and 63.7%, 3-year local recurrence-free survival rate in complete responders was 71%. In univariate analysis, hydronephrosis, lymph vessel invasion, and macroscopic residual tumor were significantly predictive of disease progression. Hydronephrosis and lymph vessel invasion were also associated with a higher risk of local recurrence. The actuarial 3-year progression-free and overall survival rates were 40.1% and 56.9%, respectively.
CONCLUSION: Radiotherapy is an effective treatment option in terms of local control and survival even in elderly patients with locally advanced bladder cancer not suitable for cystectomy.

Entities:  

Mesh:

Year:  2010        PMID: 20354664     DOI: 10.1007/s00066-010-2053-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  54 in total

1.  Image-guided radiotherapy of bladder cancer: bladder volume variation and its relation to margins.

Authors:  Ludvig Paul Muren; Anthony Thomas Redpath; Hannah Lord; Duncan McLaren
Journal:  Radiother Oncol       Date:  2007-08-09       Impact factor: 6.280

2.  Outcomes of radical cystectomy.

Authors:  George N Thalmann; John P Stein
Journal:  BJU Int       Date:  2008-11       Impact factor: 5.588

Review 3.  Trimodality treatment and selective organ preservation for bladder cancer.

Authors:  Claus Rödel; Christian Weiss; Rolf Sauer
Journal:  J Clin Oncol       Date:  2006-12-10       Impact factor: 44.544

4.  Organ-sparing treatment in muscle-invasive bladder cancer.

Authors:  Jürgen Dunst; Andrea Diestelhorst; Reinhard Kühn; Arndt-Christian Müller; Hans-Jörg Scholz; Paolo Fornara
Journal:  Strahlenther Onkol       Date:  2005-10       Impact factor: 3.621

5.  Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.

Authors:  Donatella Tirindelli Danesi; Giorgio Arcangeli; Enrico Cruciani; Pierluigi Altavista; Antonella Mecozzi; Bianca Saracino; Filina Orefici
Journal:  Cancer       Date:  2004-12-01       Impact factor: 6.860

6.  Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer.

Authors:  Filippo Sogni; Maurizio Brausi; Bruno Frea; Carlo Martinengo; Fabrizio Faggiano; Alessandro Tizzani; Paolo Gontero
Journal:  Urology       Date:  2008-03-20       Impact factor: 2.649

7.  Pretreatment proliferation and local control in bladder cancer after radiotherapy with or without concurrent chemotherapy.

Authors:  Christian Weiss; Franz Rödel; Oliver Ott; Dirk Gerhard Engehausen; Thomas Papadopoulos; Rolf Sauer; Claus Rödel
Journal:  Strahlenther Onkol       Date:  2007-10       Impact factor: 3.621

Review 8.  Bladder preservation: optimizing radiotherapy and integrated treatment strategies.

Authors:  Raymond H Mak; Anthony L Zietman; Niall M Heney; Donald S Kaufman; William U Shipley
Journal:  BJU Int       Date:  2008-11       Impact factor: 5.588

9.  Nerve-sparing radical cystectomy and orthotopic bladder replacement in female patients.

Authors:  Nivedita Bhatta Dhar; Thomas M Kessler; Robert D Mills; Fiona Burkhard; Urs E Studer
Journal:  Eur Urol       Date:  2007-03-05       Impact factor: 20.096

10.  External beam radiation therapy followed by interstitial radiotherapy with iridium-192 for solitary bladder tumours: results of 111 treated patients.

Authors:  Ilze E W van Onna; Jorg R Oddens; Esther T Kok; R Jeroen A van Moorselaar; J L H Ruud Bosch; Jan J Battermann
Journal:  Eur Urol       Date:  2008-08-21       Impact factor: 20.096

View more
  4 in total

1.  Prognostic value and efficacy valuation of postoperative intravesical instillation in primary urothelial carcinomas of upper urinary tract.

Authors:  Xiaheng Deng; Xiao Yang; Yidong Cheng; Xuzhong Liu; Bian Wu; Zijie Wang; Zhengkai Huang; Kang Liu; Ruizhe Zhao; Jun Wang; Qiang Lu; Chao Qin; Changjun Yin
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Muscle-invasive bladder cancer treated with TURB followed by concomitant boost with small reduction of radiotherapy field with or without of chemotherapy.

Authors:  Jadwiga Nowak-Sadzikowska; Tomasz Skóra; Bogumiła Szyszka-Charewicz; Jerzy Jakubowicz
Journal:  Rep Pract Oncol Radiother       Date:  2015-09-29

3.  Organ preservation for muscle-invasive bladder cancer by preoperative intra-arterial chemotherapy and transurethral resection.

Authors:  Bangmin Han; Shengjie Liang; Yifeng Jing; Di Cui; Xiao An; Qingsong Zou; Haibin Wei; Shujie Xia
Journal:  Med Oncol       Date:  2014-03-14       Impact factor: 3.064

4.  Clinical results of conformal versus intensity-modulated radiotherapy using a focal simultaneous boost for muscle-invasive bladder cancer in elderly or medically unfit patients.

Authors:  Lotte J Lutkenhaus; Rob M van Os; Arjan Bel; Maarten C C M Hulshof
Journal:  Radiat Oncol       Date:  2016-03-18       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.